Senate panel report on Dengvaxia due for debate

Published April 27, 2018, 10:00 PM

by Mario Casayuran and Vanne Elaine Terrazola

By Hannah L. Torregoza

Senator Richard Gordon on Friday confirmed that the Senate Blue Ribbon committee report on the controversial anti-dengue vaccine Dengavxia he earlier released has garnered 14 signatures and is now ready to undergo plenary debate.

Gordon, chairman of the Senate Blue Ribbon panel, said this means that the recommendations stated under the report, which includes the filing of possible graft charges against former President Benigno Aquino III, would be discussed in plenary and debated on.

“With 14 senators signing the committee report, I am happy that it will be discussed on the floor finally where it should be discussed,” Gordon said in a statement.

“I recognize that not all of my colleagues agree with the report, but I am willing to debate and discuss it on the floor,” he said.

Gordon, likewise said, he is grateful to his colleagues who signed the report to pave the way for its discussion in plenary.

Senate President Pro Tempore Ralph Recto earlier said majority of those who signed, signed with reservations, rejecting the recommendation to file a graft case against Aquino.